Cargando…
Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
Alzheimer’s disease (AD) is a neurodegenerative disorder that impairs mainly the memory and cognitive function in elderly. Extracellular beta amyloid deposition and intracellular tau hyperphosphorylation are the two pathological events that are thought to cause neuronal dysfunction in AD. Since the...
Autores principales: | Hong-Qi, Yang, Zhi-Kun, Sun, Sheng-Di, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514124/ https://www.ncbi.nlm.nih.gov/pubmed/23210837 http://dx.doi.org/10.1186/2047-9158-1-21 |
Ejemplares similares
-
Advances and considerations in AD tau-targeted immunotherapy
por: Bittar, Alice, et al.
Publicado: (2019) -
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
por: Duan, Yale, et al.
Publicado: (2012) -
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
por: Plotkin, Steven S., et al.
Publicado: (2020) -
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
por: Trojanowski, John Q
Publicado: (2013) -
Immunotherapy for the treatment of Alzheimer’s disease: amyloid-β or tau, which is the right target?
por: Castillo-Carranza, Diana L, et al.
Publicado: (2013)